You are here: Industry Insights > Merck

News List

Merck introduces Mobius MyWay portfolio for customized single-use assemblies cphi-online
March 31, 2017
Offers more flexibility, better supply predictability and shorter lead times for more efficient and safer drug manufacture.
Merck advances R&D strategy through unique development model with Avillion for Anti IL-17 A/F Nanobo worldpharmanews
March 31, 2017
Merck, a leading science and technology company, today announced a development agreement with Avillion, a UK-based company focused on increasing R&D output through innovative models, for anti IL-17 A/F Nanobody®.
Merck Launches Mobius MyWay Portfolio contractpharma
March 22, 2017
Designed to provide more flexibility, better supply predictability and shorter lead times for drug manufacture
Merck Accelerator hits new peak of applications worldpharmanews
March 22, 2017
Merck, a leading science and technology company, announced today the new startups participating in its Accelerator programs in Darmstadt, Germany and Nairobi, Kenya.
Merck introduces Millipore Express high area filters for more effective processing and optimum yield cphi-online
March 21, 2017
Greater filtration capacity with a smaller footprint than conventional filters, improving economics for biopharmaceutical manufacturing.
FDA Approves Merck’s KEYTRUDA® for Adult and Pediatric Patients with Classical Hodgkin Lymphoma (cHL americanpharmaceuticalreview
March 17, 2017
Merck has announced that the U.S. Food and Drug Administration (FDA) has approved KEYTRUDA® (pembrolizumab), the company’s anti-PD-1 (programmed death receptor-1) therapy.
Biocartis and Merck partnership launch second liquid biopsy assay europeanpharmaceuticalreview
March 16, 2017
Biocartis and Merck have launched the Idylla ctNRAS-BRAF-EGFR S492R Mutation Assay (Research Use Only).
NICE expands positive recommendation for Erbitux as first-line treatment for RAS wild-type mCRC pharmaasia
March 16, 2017
NICE's recommendation is a significant step forward in Merck's aspiration to ensure cancer patients have optimal access to effective treatments worldwide
Merck and Pfizer’s diabetes therapy under US, EU review pharmatimes
March 08, 2017
Regulators on both sides of the Atlantic are reviewing three new submissions for medicines containing ertugliflozin, an investigational SGLT2 inhibitor being developed by ...
Merck's Allergopharma opens €42m biopharmaceutical plant pharmafile
March 08, 2017
Allergopharma, a subsidiary of Germany’s Merck, has completed construction on its new €42 million biopharmaceutical facility and declared it open for business.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 51 52 Next page